BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patrussi L, Manganaro N, Capitani N, Ulivieri C, Tatangelo V, Libonati F, Finetti F, Frezzato F, Visentin A, D'Elios MM, Trentin L, Semenzato G, Baldari CT. Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment. Blood 2021;137:2182-95. [PMID: 33181836 DOI: 10.1182/blood.2020005785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tatangelo V, Boncompagni G, Capitani N, Lopresti L, Manganaro N, Frezzato F, Visentin A, Trentin L, Baldari CT, Patrussi L. p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB. Front Oncol 2022;12:877495. [PMID: 35847884 DOI: 10.3389/fonc.2022.877495] [Reference Citation Analysis]
2 Boncompagni G, Varone A, Tatangelo V, Capitani N, Frezzato F, Visentin A, Trentin L, Corda D, Baldari CT, Patrussi L. Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation. Front Oncol 2022;12:835290. [PMID: 35392232 DOI: 10.3389/fonc.2022.835290] [Reference Citation Analysis]
3 Patrussi L, Capitani N, Baldari CT. Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia. Cancers (Basel) 2021;13:6301. [PMID: 34944921 DOI: 10.3390/cancers13246301] [Reference Citation Analysis]
4 Ringshausen I. IL-9 in CLL: sensing home and settling down! Blood 2021;137:2130-1. [PMID: 33885714 DOI: 10.1182/blood.2020009464] [Reference Citation Analysis]